RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,812 | -53.3% | 215,469 | -30.3% | 0.00% | -50.0% |
| Q2 2023 | $3,882 | +21.2% | 309,179 | +59.0% | 0.00% | +100.0% |
| Q1 2023 | $3,203 | -21.1% | 194,470 | -28.5% | 0.00% | -50.0% |
| Q4 2022 | $4,061 | -99.9% | 271,839 | +81.0% | 0.00% | -50.0% |
| Q3 2022 | $3,361,000 | +187.5% | 150,211 | +115.2% | 0.00% | +300.0% |
| Q2 2022 | $1,169,000 | -48.7% | 69,807 | -8.2% | 0.00% | -50.0% |
| Q1 2022 | $2,277,000 | – | 76,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |